(Q39330638)

11 September 2017

Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib (English)

1 reference

11 September 2017

Masato Tamura

4

0 references

author name string

Maki Uyama

series ordinal

1

1 reference

PubMed ID

22702336

11 September 2017

Mari M Sato

series ordinal

2

1 reference

PubMed ID

22702336

11 September 2017

Masamitsu Kawanami

series ordinal

3

1 reference

11 September 2017

15 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

17

1 reference

11 September 2017

7

1 reference

11 September 2017

548-558

1 reference

Proteasome inhibitors: Dozens of molecules and still counting.

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

20S proteasome and its inhibitors: crystallographic knowledge for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

The ubiquitin-proteasome pathway: on protein death and cell life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Role of proteasomes in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Wnt/beta-catenin signaling: components, mechanisms, and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Id: a target of BMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Identification of the domain of alpha-catenin involved in its association with beta-catenin and plakoglobin (gamma-catenin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Proteasome inhibitors in the treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Role of the Wnt signaling pathway in bone and tooth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Smurf control in bone cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

E3 Ubiquitin Ligase Smurf1 Mediates Core-binding Factor α1/Runx2 Degradation and Plays A Specific Role in Osteoblast Differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2443.2012.01611.X

10.1111/J.1365-2443.2012.01611.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

22702336